Final results of the US humanitarian device exemption study of the low-profile visualized intraluminal support (LVIS) device

被引:46
作者
Fiorella, David [1 ]
Arthur, Adam [2 ]
Boulos, Alan [3 ]
Diaz, Orlando [4 ]
Jabbour, Pascal [5 ]
Pride, Lee [6 ]
Turk, Aquilla S. [7 ]
Woo, Henry H. [1 ]
Derdeyn, Colin [8 ]
Millar, John [9 ]
Clifton, Andrew [10 ]
机构
[1] SUNY Stony Brook, Dept Neurosurg, Stony Brook, NY 11794 USA
[2] Methodist Hosp, Memphis, TN USA
[3] Albany Med Ctr, Albany, NY USA
[4] Methodist Houston, Houston, TX USA
[5] Thomas Jefferson Hosp, Dept Neurol Surg, Philadelphia, PA USA
[6] Univ Texas Southwestern, Dept Neuroradiol, Dallas, TX USA
[7] Med Univ South Carolina, Charleston, SC USA
[8] Washington Univ, St Louis, MO USA
[9] Wessex Neurol Ctr, Dept Neuroradiol, Southampton, Hants, England
[10] St George Hosp, Sch Med, London, England
关键词
Aneurysm; Device; Stent;
D O I
10.1136/neurintsurg-2015-011937
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Introduction The low-profile visualized intraluminal support (LVIS) device is a new, braided, intracranial microstent designed for stent-assisted coiling. Objective To present the results of a single-arm, prospective, multicenter trial of the LVIS for treatment of wide-necked intracranial aneurysms. Methods 31 patients with unruptured, wide-necked (neck >= 4 mm or dome:neck ratio <= 2) intracranial aneurysms were treated with the LVIS device and bare platinum coils at six US centers (investigational device exemption G110014). Clinical follow-up was conducted at 30 days and 6 months. Angiographic follow-up was performed at 6 months. The primary safety endpoint was any major stroke or death within 30 days or major ipsilateral stroke or neurological death within 6 months. 'Probable benefit' was defined as >= 90% angiographic occlusion at 6 months. An independent core laboratory adjudicated the angiographic results. An independent clinical events committee adjudicated the clinical endpoints. Results Average aneurysm size was 7.2 mm (SD 3.8) and average neck width was 4.6 mm (SD 1.8). 68% of patients had a dome:neck ratio <= 2. LVIS placement was technically successful in 29/31 patients (93.5%). No primary safety endpoints occurred during the study (0%). No patient had a higher modified Rankin Score at 6 months than at baseline. 26/28 (92.9%) treated aneurysms with 6-month angiographic follow-up demonstrated >= 90% angiographic occlusion. 21/28 (75%) were completely occluded at follow-up. Conclusions The LVIS device facilitated the coil embolization of wide-necked intracranial aneurysms with high rates of technical success, an excellent safety profile, and very high rates of complete and near-complete occlusion at follow-up.
引用
收藏
页码:894 / 897
页数:4
相关论文
共 13 条
  • [1] Fiorella D., Albuquerque F.C., Deshmukh V.R., Et al., Usefulness of the neuroform stent for the treatment of cerebral aneurysms: Results at initial (3-6-mo) follow-up, Neurosurgery, 56, pp. 1191-1201, (2005)
  • [2] Fiorella D., Albuquerque F.C., Han P., Et al., Preliminary experience using the neuroform stent for the treatment of cerebral aneurysms, Neurosurgery, 54, pp. 6-16, (2004)
  • [3] Fiorella D., Albuquerque F.C., Woo H., Et al., Neuroform stent assisted aneurysm treatment: Evolving treatment strategies, complications and results of long term follow-up, J Neurointerv Surg, 2, pp. 16-22, (2010)
  • [4] Mocco J., Snyder K.V., Albuquerque F.C., Et al., Treatment of intracranial aneurysms with the enterprise stent: A multicenter registry, J Neurosurg, 110, pp. 35-39, (2009)
  • [5] Klisch J., Clajus C., Sychra V., Et al., Coil embolization of anterior circulation aneurysms supported by the solitaire AB neurovascular remodeling device, Neuroradiology, 52, pp. 349-359, (2010)
  • [6] Klisch J., Eger C., Sychra V., Et al., Stent-Assisted coil embolization of posterior circulation aneurysms using Solitaire AB: Preliminary experience, Neurosurgery, 65, pp. 258-266, (2009)
  • [7] Spiotta A.M., Miranpuri A., Chaudry M.I., Et al., Combined balloon stent technique with the Scepter C balloon and low-profile visualized intraluminal stent for the treatment of intracranial aneurysms, J Neurointerv Surg, 5, pp. iii79-iii82, (2013)
  • [8] Turner R.D., Turk A., Chaudry I., Low-profile visible intraluminal support device: Immediate outcome of the first three US cases, J Neurointerv Surg, 5, pp. 157-160, (2013)
  • [9] Pardo M.I., Pumar J.M., Blanco M., Et al., Medium-Term results using the leo self-expanding stent in the treatment of complex intracranial aneurysms, Neuroradiol J, 21, pp. 704-711, (2008)
  • [10] Benndorf G., Claus B., Strother C.M., Et al., Increased cell opening and prolapse of struts of a neuroform stent in curved vasculature: Value of angiographic computed tomography: Technical case report, Neurosurgery, 58, 4, (2006)